- Q2 2024 Senzime AB (publ) Earnings Call Transcript1 day ago€0.652 (-10.68%)Earnings
- Q1 2024 Senzime AB (publ) Earnings Call TranscriptMay 07, 2024€0.585 (-2.34%)Earnings
- Q3 2023 Senzime AB (publ) Earnings Call TranscriptOct 26, 2023€0.512 (-3.76%)Earnings
- Q2 2023 Senzime AB (publ) Earnings Call TranscriptAug 24, 2023€0.3985 (+4.18%)Earnings
Q1 2024 Senzime AB (publ) Earnings Call Transcript
Hello and welcome to this live Q&A with Senzime's, CEO, Philip Siberg. Thank you. We will start off with a short introduction of the company and the quarterly reports go ahead.
()-
All right. Thank you. Okay. Senzime medical device company, where the field of perioperative precision based patient monitoring, I would hit into the numbers right away and come back into the company. Okay, but Q1 was another record sales growth quarter. We saw good growth, 66% growth. We reached SEK12.1 million in sales. And the US is the main driver of 75% of the business and also the main driver of growth.
The, what we can see here is that [today]. I'm sorry, the dynamics of the business up the run rate really took off. So I'm losing my voice again. Okay. But let me just take it second.
Yes. So that's not a motivated.
Okay. So momentum in the business is good. And if you look at our net sales rolling 12 months, we're in a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)